The DOI matches its Crossref record; 405 of the 406 references it cites were found in a registry or an index.
Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications
Open accessAbstract
SUMMARY: The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past decade has provided a challenge to diagnostic microbiologists to detect these strains, clinicians treating patients with infections due to these strains, and researchers attempting to understand the resistance mechanisms. Recent data show that these strains have been detected globally and in many cases are associated with glycopeptide treatment failure; however, more rigorous clinical studies are required to clearly define the contribution of hVISA to glycopeptide treatment outcomes. It is now becoming clear that sequential point mutations in key global regulatory genes contribute to the hVISA and VISA phenotypes, which are associated predominately with cell wall thickening and restricted vancomycin access to its site of activity in the division septum; however, the phenotypic features of these strains can vary because the mutations leading to resistance can vary. Interestingly, changes in the staphylococcal surface and expression of agr are likely to impact host-pathogen interactions in hVISA and VISA infections. Given the subtleties of vancomycin susceptibility testing against S. aureus , it is imperative that diagnostic laboratories use well-standardized methods and have a framework for detecting reduced vancomycin susceptibility in S. aureus .
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to the difficulties on detecting these strains, vancomycin failures have been increasingly reported in deep-seated infections.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Indeed, S. aureus within the range of susceptibility, with vancomycin MICs > 1 and ≤ 2 μg/ml have been more frequently associated with the hVISA phenotype.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“These global homeostatic changes appear to lead to a reduced autolytic activity with thickened cell wall and an increase amount of free D-Ala-D-Ala dipeptides with less peptidoglycan cross-linking (101, 104).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Phenotypically, hVISA/VISA strains exhibit distinct metabolic characteristics that may include i) increase in fructose utilization, ii) increased fatty acid metabolism, iii) impaired acetate metabolism and tricarboxylic acid cycle, iv) decrease in glutamate availability, and iv) increase expression of cell wall synthesis genes.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“As the “resistant” subpopulation is difficult to identify, detection of hVISA becomes very challenging and some S. aureus strains reported as “susceptible” to vancomycin by standard susceptibility testing may still exhibit this phenotype (101).”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“In addition, VISA strains bind vancomycin more avidly than their non –VISA counterparts, however, diffusion of the antibiotic molecule into the inner part of the cell wall appears to be impaired.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
In the citing paper
“Finally, a striking feature of many hVISA/VISA strains is the ability to revert from one phenotype to another (or even to a fully vancomycin susceptible phenotype) in the absence of vancomycin exposure.”
From Mechanisms of Antibiotic Resistance (2016) · cites this paper as [101]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
Staphylococcus aureus Infections
Lowy, F. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808203390806 · Cited by 6,018
Klevens, R. M. (2007) · JAMA · doi:10.1001/jama.298.15.1763 · Cited by 3,726
Lew, D. P., & Waldvogel, F. A. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16727-5 · Cited by 1,988
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
Hiramatsu, K. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.1.135 · Cited by 1,984
Vandenesch, F., Naimi, T. S., Enright, M. C., Lina, G., Nimmo, G. R., Heffernan, H., Liassine, N., Bes, M., Greenland, T., Reverdy, M. E., et al. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030089 · Cited by 1,718
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
The Changing Epidemiology of Staphylococcus aureus ?
Chambers, H. F. “. (2001) · Emerging infectious diseases · doi:10.3201/eid0702.010204 · Cited by 1,419
Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium
Leclercq, R., Derlot, E., Duval, J., & Courvalin, P. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198807213190307 · Cited by 1,411
Diekema, D. J., Pfaller, M. A., Schmitz, F., Smayevsky, J., Bell, J. M., Jones, R. N., Beach, M. L., & SENTRY Participants Group (2001) · Clinical Infectious Diseases · doi:10.1086/320184 · Cited by 1,363
Research works printed but not linked: 1
- Ferraz, V., A. G. Duse, M. Kassel, A. D. Black, T. Ito, and K. Hiramatsu. 2000. Vancomycin-resistant Staphylococcus aureus occurs in South Africa. S. Afr. Med. J.90:1113.
Cited by
Sorted by citations
Items 501–600 of 962
Preliminary study on the effect of brazilin on biofilms of Staphylococcus aureus
Peng, D., Chen, A., Shi, B., Min, X., Zhang, T., Dong, Z., Yang, H., Chen, X., Tian, Y., & Chen, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6403 · Cited by 14
Phillips, C. J., Wisdom, A. J., McKinnon, R. A., Woodman, R. J., & Gordon, D. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s176519 · Cited by 14
Mirani, Z. A., Mirani, Z. A., & Jamil, N. (2012) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-012-0447-y · Cited by 14
Bhattarai, S., Marsh, L., Knight, K., Ali, L., Gomez, A., Sunderhaus, A., & Aziz, M. H. A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04861-22 · Cited by 13
Adeyemi, F. M., Oyedara, O. O., Yusuf-Omoloye, N. A., Ajigbewu, O. H., Ndaji, O. L., Adegbite-Badmus, M. K., Olumakinde, T. S., & Oluokun, T. E. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03660-3 · Cited by 15
Saleh, M., Lefèvre, S., Acar, N., Bourcier, T., Marcellin, L., Prévost, G., Subilia, A., Gaucher, D., & Jehl, F. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8417 · Cited by 13
Lasek‐Nesselquist, E., Lu, J., Schneider, R. F., Ma, Z., Russo, V. C., Mishra, S. S., Pai, M. P., Pata, J. D., McDonough, K. A., & Malik, M. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00345 · Cited by 13
Baseri, N., Peerayeh, S. N., & Bakhshi, B. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104628 · Cited by 13
Miller, C. R., Monk, J. M., Szubin, R., & Berti, A. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258592 · Cited by 13
Chang, S., Liu, T.-P., Chen, C., Lin, L.-C., & Lu, J. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.12.006 · Cited by 13
Mehla, K., & Ramana, J. (2015) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2015.0046 · Cited by 13
Zelenitsky, S. A., Alkurdi, N., Weber, Z., Ariano, R. E., & Zhanel, G. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01472-10 · Cited by 13
Rodríguez, C. A., Agudelo, M., Aguilar, Y., Zuluaga, A. F., & Vesga, Ó. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155806 · Cited by 13
Baseri, N., Peerayeh, S. N., & Amiri, F. B. (2018) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2018.06.018 · Cited by 13
Peng, H., Rao, Y., Yuan, W., Zheng, Y., Shang, W., Hu, Z., Yang, Y., Tan, L., Xiong, K., Li, S., et al. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02955 · Cited by 13
Abdul‐Mutakabbir, J. C., Kebriaei, R., Stamper, K. C., Sheikh, Z., Maassen, P. T., Lev, K. L., & Rybak, M. J. (2020) · Antibiotics · doi:10.3390/antibiotics9100696 · Cited by 13
Entenza, J. M., Veloso, T. R., Vouillamoz, J., Giddey, M., & Moreillon, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00811-10 · Cited by 13
Infection control in the operating room
Loftus, R. W. (2016) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0000000000000300 · Cited by 13
Current status of multidrug-resistant bacteria
Kim, D., & Jeong, S. H. (2022) · Journal of Korean Medical Association · doi:10.5124/jkma.2022.65.8.468 · Cited by 12
Quan, K., Mao, Z., Lu, Y., Qin, Y., Wang, S., Yu, C., Bi, X., Tang, H., Ren, X., Chen, D., et al. (2024) · Materials Horizons · doi:10.1039/d4mh00097h · Cited by 13
Chaudhary, K., Agrahari, B., Biswas, B., Chatterjee, N., Chaudhary, A., Kumar, A., Sonker, H., Dewan, S., Saxena, D., Akhir, A., et al. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400378 · Cited by 12
Yu, R., Dale, S. E., Yamamura, D. L. R., Stankus, V., & Lee, C. (2012) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2012/138470 · Cited by 12
Bataineh, S. M. B., Tarazi, Y. H., & Ahmad, W. A. (2021) · Applied Sciences · doi:10.3390/app11188479 · Cited by 12
Castro, B. E., Ríos, R., Carvajal, L. P., Vargas, M. L., Cala, M. P., León, L., Hanson, B., Dinh, A. Q., Ortega‐Recalde, O., Seas, C., et al. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac363 · Cited by 12
Current and emerging drugs for acute bacterial skin and skin structure infections: an update
Kollipara, R., Downing, C. P., Lee, M. H.-Y., Guidry, J. A., Curtis, S., & Tyring, S. K. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.955015 · Cited by 12
Risk factors for mortality in patients withStaphylococcus aureusbloodstream infection
Rosa, F. G. D., Corcione, S., Motta, I., Petrolo, A., Filippini, C., Pagani, N., Fossati, L., Cavallo, R., & Perri, G. D. (2015) · Journal of Chemotherapy · doi:10.1179/1973947815y.0000000076 · Cited by 12
Kapkoti, D. S., Gupta, V. K., Darokar, M. P., & Bhakuni, R. S. (2016) · MedChemComm · doi:10.1039/c5md00527b · Cited by 12
Agrawal, D. C. (2015) · JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH · doi:10.7860/jcdr/2015/10072.6625 · Cited by 12
Божкова, С. А., Муртузалиевич, Т. Р., Краснова, М. В., & Rukina, A. N. (2013) · Traumatology and Orthopedics of Russia · doi:10.21823/2311-2905-2013--4-5-15 · Cited by 12
Vimberg, V., Cavanagh, J. P., Benada, O., Kofroňová, O., Hjerde, E., Zieglerová, L., & Novotna, G. B. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.11.007 · Cited by 12
Wu, Z., & Boger, D. L. (2019) · Tetrahedron · doi:10.1016/j.tet.2019.02.008 · Cited by 12
Sumon, Z. E., Berenson, C. S., Sellick, J. A., Bulman, Z. P., Tsuji, B. T., & Mergenhagen, K. A. (2019) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2018.1533646 · Cited by 12
Mayandi, V., Sridhar, S., Fazil, M. H. U. T., Goh, E. T. L., Htoon, H. M., Orive, G., Choong, Y. K., Saravanan, R., Beuerman, R. W., Barkham, T., et al. (2019) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.9b00102 · Cited by 12
Choi, S., Moon, S. M., Park, S., Lee, S. C., Jung, K. H., Sung, H., Kim, M., Jung, J., Kim, M. J., Kim, S., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01925-19 · Cited by 12
Kim, J. W., & Lee, K. J. (2020) · Archives of Microbiology · doi:10.1007/s00203-020-01906-y · Cited by 15
Zhang, S., Wang, P., Shi, X., & Tan, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-86647-8 · Cited by 12
Errecalde, L., Ceriana, P., Gagetti, P. S., Erbín, M., Duarte, A. I. E., Rolón, M. J., Cuatz, D., Corso, A. C., & Kaufman, S. C. (2013) · Revista Argentina de Microbiología · doi:10.1016/s0325-7541(13)70007-5 · Cited by 12
Glycopeptides: An Old but Up-to-Date Successful Antibiotic Class
Marcone, G. L., & Marinelli, F. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8_5 · Cited by 12
Emerging Vancomycin Resistance
Jones, D. B. (2010) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.105 · Cited by 12
Management of Diabetic Wounds: Expert Panel Consensus Statement
Hsia, H. C., Eriksson, E. K., Gurtner, G. C., Veves, A., Hamdy, O., Margolis, D. J., Armstrong, D. G., Lavery, L. A., Grice, E., Schultz, G., et al. (2025) · Advances in Wound Care · doi:10.1177/21621918251366586 · Cited by 12
Herrera, M., Gregorio, S. D., Haim, M. S., Posse, G., Mollerach, M. E., & Conza, J. D. (2021) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2021.106304 · Cited by 11
Wang, Y., Zhou, Y., Shi, C., Liu, J., Lv, G., Huang, H., Li, S., Duan, L., Zheng, X., Liu, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34034-w · Cited by 11
Mei, Q., Ye, Y., Zhu, Y., Cheng, J., Yang, H., Liu, Y., Li, H.-R., & Li, J. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.01.018 · Cited by 11
Park, S.-Y., Oh, I., Lee, H.-J., Ihm, C., Son, J. S., Lee, M. S., & Kim, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01137-13 · Cited by 11
Mirza, H. C., Sancak, B., & Gür, D. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2015.0048 · Cited by 11
Therapeutic Options and Emerging Alternatives for Multidrug Resistant Staphylococcal Infections
Magana, M., Ioannidis, A., Magiorkinis, E., Ursu, O., Bologa, C., Chatzipanagiotou, S., Hamblin, M. R., & Tegos, G. P. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150310101851 · Cited by 11
Zorgani, A., Elahmer, O., Abaid, A., Elaref, A., Elamri, S., Aghila, E., & Tubbal, A. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.6976 · Cited by 11
A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin ‘in-chloride’
Wadzinski, T. J., Gea, K. D., & Miller, S. J. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.12.027 · Cited by 11
Identification of a conserved linear B-cell epitope in the Staphylococcus aureus GapC protein
Wang, M., Wei, Y., Yu, W., Wang, L., Zhai, L., Li, X., Wang, X., Zhang, H., Feng, Z., Yu, L., et al. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.03.007 · Cited by 11
Reilly, J., Jacobs, M. A., Friedman, B. C., Cleveland, K. O., Lombardi, D. A., & Castañeda-Ruiz, B. (2020) · Drugs - Real World Outcomes · doi:10.1007/s40801-020-00191-x · Cited by 11
Mazumdar, A., & Adam, V. (2021) · Journal of Molecular and Clinical Medicine · doi:10.31083/j.jmcm.2021.01.208 · Cited by 11
Basri, D. F., Jaffar, N., Zin, N. M., & Raj, L. S. (2013) · International Journal of Pharmacology · doi:10.3923/ijp.2013.150.156 · Cited by 11
Factors affecting susceptibility of Staphylococcus aureus to antibacterial agents
Kawada‐Matsuo, M., & Komatsuzawa, H. (2012) · Journal of Oral Biosciences · doi:10.1016/j.job.2012.04.001 · Cited by 11
Silveira, A. C. D. O., Sambrano, G. E., Paim, T. G. D. S., Caierão, J., de Córdova, C. M. M., & d’Azevedo, P. A. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.04.008 · Cited by 11
Buntaran, L., Hatta, M., Sultan, A. R., Dwiyanti, R., & Sabir, M. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-110 · Cited by 11
Ramli, S. R., Neoh, H., Aziz, M. N., & Hussin, S. (2012) · Infectious Disease Reports · doi:10.4081/idr.2012.e20 · Cited by 11
Gregorio, S. D., Fernández, S., Cuirolo, A., Verlaine, O., Amoroso, A. M., Mengin‐Lecreulx, D., Famiglietti, A. M. R., Joris, B., & Mollerach, M. E. (2016) · Microbial Drug Resistance · doi:10.1089/mdr.2016.0160 · Cited by 11
Hesketh, A. R., Deery, M. J., & Hong, H. (2015) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00242 · Cited by 11
Molecular Mechanisms of Antibiotic Resistance – Part II
Sharkey, L. K. R., & O’Neill, A. J. (2019) · Wiley eBooks · doi:10.1002/9781119593522.ch2 · Cited by 11
Shen, X., Zhang, J., Ou, J., Bai, Z., Liu, T., Zhang, K., Zhu, K., Wang, J. Q., Wang, C., Zhang, Q., et al. (2025) · Advanced Science · doi:10.1002/advs.202512355 · Cited by 10
Wang, W., Chiu, C.-F., Lee, Y., Hsueh, P., & Tsao, S. (2021) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2021.09.003 · Cited by 10
Akunuri, R., Unnissa, T., Vadakattu, M., Bujji, S., Ghouse, S. M., Yaddanapudi, V. M., Chopra, S., & Nanduri, S. (2022) · ChemistrySelect · doi:10.1002/slct.202201403 · Cited by 10
Kang, Y. R., Chung, D. R., Ko, J., Huh, K., Cho, S. Y., Kang, C., & Peck, K. R. (2023) · Antibiotics · doi:10.3390/antibiotics12040711 · Cited by 10
Land, A. D., Hogan, P. G., Fritz, S. A., & Levin, P. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129670 · Cited by 9
Joo, J., Yamaki, J., Lou, M., Hshieh, S., Chu, T. N. T., Shriner, K. A., & Wong‐Beringer, A. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.05.018 · Cited by 10
Menegotto, F., González-Cabrero, S., Lorenzo, B., Cubero, Á., Cuervo, W., Gutiérrez, M. P., Simarro, M., Orduña, A., & Bratos, M. Á. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.08.001 · Cited by 10
Structure–activity exploration of a small-molecule Lipid II inhibitor
de Leeuw, E., Fletcher, S., Yu, W., Huang, J., Kwasny, S. M., Chauhan, J., Opperman, T. J., & MacKerell, A. D. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s79504 · Cited by 10
An educational intervention to improve vancomycin prescribing and monitoring
Phillips, C. J., Doan, H., Quinn, S. J., Kirkpatrick, C. M. J., Gordon, D., & Doogue, M. P. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.11.010 · Cited by 10
Moreillon, P., Bizzini, A., Giddey, M., Vouillamoz, J., & Entenza, J. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr521 · Cited by 10
Singh, A. K., Prasad, K. N., Rahman, M., Rai, R. P., Singh, S. K., & Srivastava, J. K. (2017) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2016.11.006 · Cited by 10
Tabuchi, F., Matsumoto, Y., Ishii, M., Tatsuno, K., Okazaki, M., Sato, T., Moriya, K., & Sekimizu, K. (2017) · The Journal of Antibiotics · doi:10.1038/ja.2017.56 · Cited by 10
Xu, J., Pang, L., Xue, X., Hu, J., Tian, Y., Yang, Y. L., & Sun, D. (2018) · Open Medicine · doi:10.1515/med-2018-0071 · Cited by 10
Microbial Resistance and Superbugs
Jones, L. S., & Howe, R. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397043-5.00015-3 · Cited by 9
Kang, Y. R., Kim, S., Chung, D. R., Ko, J., Huh, K., Cho, S. Y., Kang, C., & Peck, K. R. (2022) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-022-01140-9 · Cited by 10
Yamuna Devi Punithavathy, P. M. (2015) · Clinical Microbiology Open Access · doi:10.4172/2327-5073.1000214 · Cited by 9
hVISA and MRSA endocarditis: an 8-year experience in a tertiary care centre
Maor, ., Belausov, N., Ben-David, D., Smollan, G., Keller, N., & Rahav, G. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12498 · Cited by 10
Antimicrobial Resistance in Gram-positive Cocci: Past 50 Years, Present and Future
Song, J. (2011) · Infection and Chemotherapy · doi:10.3947/ic.2011.43.6.443 · Cited by 11
Guignard, B., Vouillamoz, J., Giddey, M., & Moreillon, P. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1824-x · Cited by 10
Rossolini, G. M., Arena, F., & Pollini, S. (2013) · Springer eBooks · doi:10.1007/978-3-642-39968-8_2 · Cited by 11
Hira, J., Singh, B., Halder, T., Mahmutovic, A., Ajayi, C., Sekh, A. A., Hegstad, K., Johannessen, M., & Lentz, C. S. (2024) · Communications Biology · doi:10.1038/s42003-024-06894-z · Cited by 10
Williams, A., Coombs, G. W., Bell, J. M., Daley, D. A., Mowlaboccus, S., Bryant, P. A., Campbell, A. J., Cooley, L., Iredell, J. R., Irwin, A., et al. (2024) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piae110 · Cited by 9
Tawfeek, C. E., Khattab, S., Elmaraghy, N., Heiba, A. A., & Nageeb, W. M. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-10047-2 · Cited by 9
Neto, A. M. B., Rabelo, M. A., Lima, J. L. D. C., Loibman, S. O., Leal, N. C., & Maciel, M. A. V. (2018) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/0037-8682-0159-2017 · Cited by 9
Thomas, P., Deming, M., & Sarkar, A. (2022) · ACS Omega · doi:10.1021/acsomega.2c04381 · Cited by 9
Lee, J. Y. H., & Howden, B. P. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1041924 · Cited by 9
Self-citationChallenges in the microbiological diagnosis and management of hVISA infections
Cheong, J. W. S., Harris, P. N. A., Oman, K. M., & Norton, R. E. (2011) · Pathology · doi:10.1097/pat.0b013e3283464ca3 · Cited by 9
Vancomycin Resistance in Ocular Infections
Gupta, M., Durand, M. L., & Sobrin, L. (2011) · International Ophthalmology Clinics · doi:10.1097/iio.0b013e31822d67c7 · Cited by 10
Gomes, R. M., & Bomfim, M. R. Q. (2015) · Chemotherapy Open access · doi:10.4172/2167-7700.1000149 · Cited by 8
Bakthavatchalam, Y. D., Veeraraghavan, B., Peter, J. V., Rajinikanth, J., Inbanathan, F. Y., Ragupathi, N. K. D., & Sekar, S. K. R. (2016) · Genome Announcements · doi:10.1128/genomea.01425-16 · Cited by 9
Monteiro, A. D. S., Neto, W. R. N., Mendes, A. R. S., Pinto, B. L. D. S., da Silva, L. C. N., & Ferreira, G. F. (2017) · InTech eBooks · doi:10.5772/66954 · Cited by 9
Çapın, B. B. Ö., Tekelı, A., & Karahan, Z. C. (2019) · Microbial Drug Resistance · doi:10.1089/mdr.2019.0178 · Cited by 9
Farrington, M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-7020-4084-9.00052-5 · Cited by 9
Chemotherapeutic Strategies for Combating Staphylococcus aureus Infections
Sharma, N., Chhillar, A. K., Dahiya, S., Punia, A., Choudhary, P., Gulia, P., Behl, A., & Dangi, M. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210402150325 · Cited by 8
Functionalized Cyclopentenones and an Oxime Ether as Antimicrobial Agents
Gomes, R. F. A., Isca, V. M. S., Andrade, K. H. S., Rijo, P. M., & Afonso, C. A. M. (2021) · ChemMedChem · doi:10.1002/cmdc.202100369 · Cited by 9
Liu, P., Hao, Z., Liu, M., Niu, M., Sun, P., Yan, S., Zhao, L., & Zhao, X. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab260 · Cited by 8
The Influence of Antibiotic Resistance on Innate Immune Responses to Staphylococcus aureus Infection
Jahan, N., Patton, T., & O’Keeffe, M. A. (2022) · Antibiotics · doi:10.3390/antibiotics11050542 · Cited by 11
Molecular epidemiology of heteroresistant vancomycin-intermediate Staphylococcus aureus in Brazil
Silveira, A. C. D. O., da Cunha, G. R., Caierão, J., de Córdova, C. M. M., & d’Azevedo, P. A. (2015) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2015.06.013 · Cited by 9
Eom, S., Lim, K.-S., & Kim, Y. (2013) · Journal of Applied Phycology · doi:10.1007/s10811-013-0034-3 · Cited by 9
Reduced vancomycin susceptibility in porcine ST9 MRSA isolates
Kwok, G. M. L., O'Donoghue, M. M., Doddangoudar, V. C., Ho, J., & Boost, M. V. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00316 · Cited by 9
, C. (2013) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2013.63.70 · Cited by 9
Metadata
- Authors
- Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L.
- Affiliations
- The University of Melbourne (AU)
- Monash University (AU)
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 23
- Issue
- 1
- Pages
- 99-139
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- PMC
- PMC2806658
- OpenAlex
- W2126915534
- Cited by
- 962
- References
- 406
- Citations by year
- 2026: 42 · 2025: 41 · 2024: 48 · 2023: 58 · 2022: 45 · 2021: 52 · 2020: 49 · 2019: 60 · 2018: 54 · 2017: 51 · 2016: 63 · 2015: 83 · 2014: 69 · 2013: 88 · 2012: 72
- FWCI
- 9.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Microbiology Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- vancomycin-intermediate Staphylococcus aureus, heterogeneous vancomycin-intermediate Staphylococcus aureus, reduced vancomycin susceptibility, glycopeptide resistance, cell wall thickening, agr gene, vancomycin susceptibility testing, treatment failure, host-pathogen interaction
- MeSH terms
- Anti-Bacterial Agents, Humans, Microbial Sensitivity Tests, Staphylococcal Infections, Staphylococcus aureus, Vancomycin, Treatment Outcome, Vancomycin Resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
